Back to Search
Start Over
Oral Selective Estrogen Receptor Degrader After Endocrine Therapy With a Cyclin-Dependent Kinase 4/6 Inhibitor.
- Source :
- Journal of Clinical Oncology; 12/20/2022, Vol. 40 Issue 36, p4280-4281, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 40
- Issue :
- 36
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 160823149
- Full Text :
- https://doi.org/10.1200/JCO.22.01454